- Home
- TRI vs BDX Comparison
TRI vs BDX Comparison
Compare TRI & BDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | TRI | BDX |
|---|---|---|
| Founded | 1851 | 1897 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | | Medical/Dental Instruments |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 55.2B | 55.5B |
| IPO Year | N/A | 1962 |
Fundamental Metrics
Financial Performance| Metric | TRI | BDX |
|---|---|---|
| Price | $93.26 | $170.40 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 11 | 9 |
| Target Price | $164.55 | ★ $207.13 |
| AVG Volume (30 Days) | ★ 2.4M | 2.1M |
| Earning Date | 02-05-2026 | 02-09-2026 |
| Dividend Yield | ★ 2.73% | 2.02% |
| EPS Growth | N/A | ★ 3.08 |
| EPS | 3.33 | ★ 6.12 |
| Revenue | $7,476,000,000.00 | ★ $21,924,000,000.00 |
| Revenue This Year | $8.86 | $3.16 |
| Revenue Next Year | $8.42 | $3.12 |
| P/E Ratio | ★ $26.80 | $33.86 |
| Revenue Growth | 3.00 | ★ 6.22 |
| 52 Week Low | $85.02 | $162.29 |
| 52 Week High | $218.42 | $235.34 |
Technical Indicators
Market Signals| Indicator | TRI | BDX |
|---|---|---|
| Relative Strength Index (RSI) | 23.39 | 24.47 |
| Support Level | $85.02 | $199.00 |
| Resistance Level | $100.96 | $211.47 |
| Average True Range (ATR) | 5.31 | 5.63 |
| MACD | -2.36 | -2.30 |
| Stochastic Oscillator | 19.70 | 10.62 |
Price Performance
Historical ComparisonAbout TRI Thomson Reuters Corp
Thomson Reuters is a leading global provider of business information services, delivering trusted data, technology, and expertise to professionals across legal, tax, accounting, risk, compliance, and the news and media sectors. Headquartered in Toronto, Canada, the company combines deep domain knowledge with data and software solutions to help clients make informed decisions, manage complexity, and drive efficiency. Thomson Reuters serves legal and accounting/tax professionals, corporations, and governments worldwide, but around 75% of revenue is generated in the US. The company is known for flagship products such as Westlaw, UltraTax CS, and Reuters News.
About BDX Becton Dickinson and Company
Becton Dickinson is the world's largest manufacturer and distributor of medical surgical products, such as needles, syringes, and sharps-disposal units. The company also manufactures prefilled devices, diagnostic instruments, and reagents, as well as flow cytometry and cell-imaging systems. BD Medical is nearly half of the total business, while BD Life Sciences (26% of 2024 revenue) and BD Interventional (25%) account for the remainder. International revenue accounts for 43% of the company's business.